Amphera recruits first patients to phase II study of MesoPher to treat pancreatic cancer

Amphera wins top ten list of most groundbreaking innovations in science

Amphera presents data of MesoPher and checkpoint inhibitor combination therapy to treat mesothelioma at AACR 2019

Amphera recruits first patients to pivotal phase II/III study of MesoPher to treat pleural mesothelioma

ZonMW Parel awarded to prof dr Joachim Aerts for his research on dendritic cell immunotherapy MesoPher for mesothelioma

World Cancer Day 2018 – Presentation of Prof dr Joachim Aerts on dendritic cell immunotherapy for mesothelioma

Dendritic cell immunotherapy is safe and clinically active in mesothelioma

Amphera is moving to a new office